Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
NCT04467983Phase 4Active, not recruiting
- Sponsor
- Hospital for Special Surgery
- Start
- Feb 2021
- Primary completion
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of abaloparatide in postmenopausal osteoporosis, sponsored by Hospital for Special Surgery. Started Feb 2021; status: active, not recruiting.
02
Drugs
abaloparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT04467983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467983.